Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1968 1
1969 1
1970 1
1971 3
1973 2
1974 1
1975 1
1976 3
1977 1
1978 3
1979 2
1980 1
1981 2
1982 2
1983 1
1984 2
1985 1
1987 1
1988 4
1989 2
1991 3
1992 1
1993 3
1994 1
1995 4
1996 4
1997 8
1998 4
1999 3
2000 6
2001 5
2002 7
2003 3
2004 11
2005 6
2006 9
2007 11
2008 10
2009 8
2010 7
2011 14
2012 16
2013 12
2014 21
2015 20
2016 21
2017 23
2018 26
2019 31
2020 52
2021 35
2022 42
2023 36
2024 24

Text availability

Article attribute

Article type

Publication date

Search Results

453 results

Results by year

Filters applied: . Clear all
Page 1
Hyperglycemia and adverse pregnancy outcomes.
HAPO Study Cooperative Research Group; Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, Oats JJ, Persson B, Rogers MS, Sacks DA. HAPO Study Cooperative Research Group, et al. N Engl J Med. 2008 May 8;358(19):1991-2002. doi: 10.1056/NEJMoa0707943. N Engl J Med. 2008. PMID: 18463375 Free article.
Primary outcomes were birth weight above the 90th percentile for gestational age, primary cesarean delivery, clinically diagnosed neonatal hypoglycemia, and cord-blood serum C-peptide level above the 90th percentile. ...For birth weight above the 90th percentile, th …
Primary outcomes were birth weight above the 90th percentile for gestational age, primary cesarean delivery, clinically diagnosed neonata …
The Term Newborn: Hypoglycemia.
Hubbard EM, Hay WW Jr. Hubbard EM, et al. Clin Perinatol. 2021 Aug;48(3):665-679. doi: 10.1016/j.clp.2021.05.013. Clin Perinatol. 2021. PMID: 34353586 Review.
This review provides an update on neonatal hypoglycemia in the term infant, including discussion of glucose metabolism, definitions of hypoglycemia, identification of infants commonly at risk, and the screening, treatment, and potential neurologic outcomes of postna …
This review provides an update on neonatal hypoglycemia in the term infant, including discussion of glucose metabolism, defini …
Neonatal hypoglycemia: lack of evidence for a safe management.
Roeper M, Hoermann H, Kummer S, Meissner T. Roeper M, et al. Front Endocrinol (Lausanne). 2023 Jun 8;14:1179102. doi: 10.3389/fendo.2023.1179102. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37361517 Free PMC article. Review.
Neonatal hypoglycemia affects up to 15% of all newborns. Despite the high prevalence there is no uniform definition of neonatal hypoglycemia, and existing guidelines differ significantly in terms of when and whom to screen for hypoglycemia, and where t …
Neonatal hypoglycemia affects up to 15% of all newborns. Despite the high prevalence there is no uniform definition of neon …
Infant of diabetic mother: what one needs to know?
Kallem VR, Pandita A, Pillai A. Kallem VR, et al. J Matern Fetal Neonatal Med. 2020 Feb;33(3):482-492. doi: 10.1080/14767058.2018.1494710. Epub 2018 Sep 9. J Matern Fetal Neonatal Med. 2020. PMID: 29947269 Review.
Early Metformin in Gestational Diabetes: A Randomized Clinical Trial.
Dunne F, Newman C, Alvarez-Iglesias A, Ferguson J, Smyth A, Browne M, O'Shea P, Devane D, Gillespie P, Bogdanet D, Kgosidialwa O, Egan A, Finn Y, Gaffney G, Khattak A, O'Keeffe D, Liew A, O'Donnell M. Dunne F, et al. JAMA. 2023 Oct 24;330(16):1547-1556. doi: 10.1001/jama.2023.19869. JAMA. 2023. PMID: 37786390 Free PMC article. Clinical Trial.
Secondary neonatal outcomes differed by group, with smaller neonates (lower mean birth weights, a lower proportion weighing >4 kg, a lower proportion in the >90% percentile, and smaller crown-heel length) in the metformin group without differences in neonatal intensive care …
Secondary neonatal outcomes differed by group, with smaller neonates (lower mean birth weights, a lower proportion weighing >4 kg, a lowe …
Comparative Efficacy and Safety of Metformin, Glyburide, and Insulin in Treating Gestational Diabetes Mellitus: A Meta-Analysis.
Guo L, Ma J, Tang J, Hu D, Zhang W, Zhao X. Guo L, et al. J Diabetes Res. 2019 Nov 4;2019:9804708. doi: 10.1155/2019/9804708. eCollection 2019. J Diabetes Res. 2019. PMID: 31781670 Free PMC article.

Of the two groups between glyburide and metformin, metformin had lower gestational weight gain compared with glyburide (MD, 1.67; 95% CI, 0.26 to 3.07; P < 0.05). Glyburide had a higher risk of neonatal hypoglycemia compared with insulin (RR, 1.76; 95% CI, 1.32 t

…
Of the two groups between glyburide and metformin, metformin had lower gestational weight gain compared with glyburide (MD, 1.67; 95% CI, 0. …
Neonatal Hypoglycemia.
Edmundson K, Jnah AJ. Edmundson K, et al. Neonatal Netw. 2024 May 1;43(3):156-164. doi: 10.1891/NN-2023-0068. Neonatal Netw. 2024. PMID: 38816219 Review.
Neonatal hypoglycemia (NH) is broadly defined as a low plasma glucose concentration that elicits hypoglycemia-induced impaired brain function. ...
Neonatal hypoglycemia (NH) is broadly defined as a low plasma glucose concentration that elicits hypoglycemia-induced impaired …
Neonatal hypoglycemia.
Adamkin DH. Adamkin DH. Curr Opin Pediatr. 2016 Apr;28(2):150-5. doi: 10.1097/MOP.0000000000000319. Curr Opin Pediatr. 2016. PMID: 26780301 Review.
PURPOSE OF REVIEW: The screening and management for neonatal hypoglycemia remains a confusing and contentious problem in neonatology. ...
PURPOSE OF REVIEW: The screening and management for neonatal hypoglycemia remains a confusing and contentious problem in neona …
Screening and diagnosing gestational diabetes mellitus.
Hartling L, Dryden DM, Guthrie A, Muise M, Vandermeer B, Aktary WM, Pasichnyk D, Seida JC, Donovan L. Hartling L, et al. Evid Rep Technol Assess (Full Rep). 2012 Oct;(210):1-327. Evid Rep Technol Assess (Full Rep). 2012. PMID: 24423035 Free PMC article. Review.
Key outcomes included preeclampsia, maternal weight gain, birth injury, shoulder dystocia, neonatal hypoglycemia, macrosomia, and long-term metabolic outcomes for the child and mother. ...Current evidence does not show that treatment of GDM has an effect on neona …
Key outcomes included preeclampsia, maternal weight gain, birth injury, shoulder dystocia, neonatal hypoglycemia, macrosomia, …
453 results